BG28264A3 - Метод за получаване на кортикоиди - Google Patents

Метод за получаване на кортикоиди

Info

Publication number
BG28264A3
BG28264A3 BG037478A BG3747877A BG28264A3 BG 28264 A3 BG28264 A3 BG 28264A3 BG 037478 A BG037478 A BG 037478A BG 3747877 A BG3747877 A BG 3747877A BG 28264 A3 BG28264 A3 BG 28264A3
Authority
BG
Bulgaria
Prior art keywords
corticoids
obtaining
proven
formulated
point
Prior art date
Application number
BG037478A
Other languages
Bulgarian (bg)
English (en)
Inventor
Klaus Annen
Henry Laurent
Helmut Hofmeister
Rudolf Wiechert
Hans Wendt
Joachim Kapp
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of BG28264A3 publication Critical patent/BG28264A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG037478A 1976-10-04 1977-10-03 Метод за получаване на кортикоиди BG28264A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2645104A DE2645104C2 (de) 1976-10-04 1976-10-04 11β-Hydroxy-1,4,8-pregnatrien-3,20-dion-Derivate und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
BG28264A3 true BG28264A3 (bg) 1980-03-25

Family

ID=5989828

Family Applications (3)

Application Number Title Priority Date Filing Date
BG037478A BG28264A3 (bg) 1976-10-04 1977-10-03 Метод за получаване на кортикоиди
BG7740392A BG28717A4 (bg) 1976-10-04 1977-10-03 Metod za poluchavane na kortikoidi
BG7840393A BG28718A4 (en) 1976-10-04 1977-10-03 Method of obtaining of corticoids

Family Applications After (2)

Application Number Title Priority Date Filing Date
BG7740392A BG28717A4 (bg) 1976-10-04 1977-10-03 Metod za poluchavane na kortikoidi
BG7840393A BG28718A4 (en) 1976-10-04 1977-10-03 Method of obtaining of corticoids

Country Status (31)

Country Link
US (2) US4176126A (cs)
JP (1) JPS5359655A (cs)
AT (1) AT358201B (cs)
AU (1) AU519212B2 (cs)
BE (1) BE859350A (cs)
BG (3) BG28264A3 (cs)
CA (1) CA1099255A (cs)
CH (4) CH634082A5 (cs)
CS (1) CS199510B2 (cs)
DD (1) DD132438A5 (cs)
DE (1) DE2645104C2 (cs)
DK (1) DK438377A (cs)
ES (1) ES462888A1 (cs)
FI (1) FI58644C (cs)
FR (1) FR2366312A1 (cs)
GB (1) GB1594371A (cs)
GR (1) GR65016B (cs)
HU (1) HU177757B (cs)
IE (1) IE45781B1 (cs)
IL (1) IL53031A (cs)
IT (1) IT1087057B (cs)
LU (1) LU78210A1 (cs)
NL (1) NL7710868A (cs)
NO (1) NO773361L (cs)
NZ (1) NZ185296A (cs)
PL (2) PL110367B1 (cs)
PT (1) PT67110B (cs)
RO (1) RO73519A (cs)
SE (1) SE431757B (cs)
SU (1) SU730311A3 (cs)
ZA (1) ZA775915B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510582B1 (fr) 1981-07-30 1986-05-30 Sipsy Steroides esterifies en la position 17 et thio-esterifies en la position 21, leur procede de preparation et leur application comme medicament
IL66432A0 (en) * 1981-08-04 1982-12-31 Plurichemie Anstalt Process for the preparation of steroidal esters
DE3243482A1 (de) * 1982-11-22 1984-05-24 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6(alpha)-methylkortikoide, ihre herstellung und verwendung
DE3248435A1 (de) * 1982-12-23 1984-06-28 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6(alpha)-methylprednisolon-derivate ihre herstellung und verwendung
US4512986A (en) * 1983-07-26 1985-04-23 Research Triangle Institute Progrestationally active steroids
JPH07116222B2 (ja) * 1989-10-26 1995-12-13 エスエス製薬株式会社 21―デスオキシプレドニゾロン―17―エステルの製造法
DE4333920A1 (de) 1993-10-05 1995-04-13 Hoechst Ag Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE4433374A1 (de) * 1994-09-20 1996-03-21 Hoechst Ag 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2808415A (en) * 1955-01-25 1957-10-01 Merck & Co Inc Delta4, 8(9)-3, 20-diketo-11, 17-dihydroxy-21-oxygenated-pregnadienes and processes of preparing the same
US2813882A (en) * 1955-01-25 1957-11-19 Merck & Co Inc delta-3, 20-diketo-17-hydroxy-11, 21-bis oxygenated-pregnadiene compounds and processes of preparing the same
GB1043347A (en) * 1963-05-10 1966-09-21 Glaxo Lab Ltd 17,21-orthoesters of steroids
GB1047518A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡-monoesters of 11,17,21-trihydroxy steroid compounds
GB1026160A (en) * 1964-04-29 1966-04-14 American Cyanamid Co Pregnatrienes
US3813420A (en) * 1969-02-05 1974-05-28 American Home Prod 13-polycarbonalkyl-3,11,17,20,21-pentaoxygenated-18-norpregnenes
GB1440064A (en) * 1972-08-11 1976-06-23 Glaxo Lab Ltd Delta8-9- steroids of the pregnane series

Also Published As

Publication number Publication date
PL111825B1 (en) 1980-09-30
ZA775915B (en) 1978-05-30
JPS5359655A (en) 1978-05-29
NO773361L (no) 1978-04-05
AU2915477A (en) 1979-04-05
FR2366312A1 (fr) 1978-04-28
CH634085A5 (de) 1983-01-14
CS199510B2 (en) 1980-07-31
LU78210A1 (cs) 1978-01-23
PT67110B (de) 1979-03-14
DE2645104A1 (de) 1978-04-06
SU730311A3 (ru) 1980-04-25
FI58644C (fi) 1981-03-10
SE7711038L (sv) 1978-04-05
IL53031A (en) 1981-06-29
ATA703477A (de) 1980-01-15
CA1099255A (en) 1981-04-14
DE2645104C2 (de) 1986-04-24
GR65016B (en) 1980-06-13
NZ185296A (en) 1980-04-28
JPS6126554B2 (cs) 1986-06-20
RO73519A (ro) 1981-06-22
CH634082A5 (de) 1983-01-14
IE45781B1 (en) 1982-12-01
GB1594371A (en) 1981-07-30
AT358201B (de) 1980-08-25
BE859350A (fr) 1978-04-04
SE431757B (sv) 1984-02-27
AU519212B2 (en) 1981-11-19
IL53031A0 (en) 1977-11-30
US4176126A (en) 1979-11-27
PL110367B1 (en) 1980-07-31
FI58644B (fi) 1980-11-28
HU177757B (en) 1981-12-28
CH634083A5 (de) 1983-01-14
DK438377A (da) 1978-04-05
BG28717A4 (bg) 1980-06-16
CH634084A5 (de) 1983-01-14
FI772921A7 (fi) 1978-04-05
IT1087057B (it) 1985-05-31
FR2366312B1 (cs) 1980-02-01
PT67110A (de) 1977-11-01
NL7710868A (nl) 1978-04-06
US4243664A (en) 1981-01-06
IE45781L (en) 1978-04-04
BG28718A4 (en) 1980-06-16
PL201162A1 (pl) 1979-01-29
DD132438A5 (de) 1978-09-27
ES462888A1 (es) 1978-06-01

Similar Documents

Publication Publication Date Title
BG38164A3 (bg) Метод за получаване на n- заместени-4-пипериданамини
BG31225A3 (bg) Метод за получаване на ациланилидни производни
BG34338A3 (bg) Метод за получаване на тиадиазолилцефалоспорини
BG33296A3 (bg) Метод за получаване на производни на 4- дезацетил- винкалевкобластин с- 3- карбоксихидразид
BG28847A3 (bg) Метод за получаване на хидантоинови производни
BG28070A4 (bg) Метод за получаване на фосфонисти киселини
BG31377A3 (bg) Метод за получаване на фенилетиламини
BG31493A3 (bg) Метод за получаване на фенетаноламини
BG28573A3 (bg) Метод за получаване на аминоалкоксифенилови производни
BG30778A3 (en) Method for obtaining of eburnamenine derivatives
BG34038A3 (bg) Метод за получаване на 7-заместени амино-ацетамидо оксадетиа-цефалоспорини
BG28264A3 (bg) Метод за получаване на кортикоиди
BG31504A3 (bg) Метод за получаване на депостероидни естери
BG31073A3 (bg) Метод за получаване на 1,5-заместени-2-пиролидони
BG32117A4 (bg) Метод за получаване олеандомицини
BG28565A3 (bg) Метод за получаване на пиролхиноксалинони и пиролбензодиазепинони
BG30021A3 (bg) Метод за получаване на имидазоизохинолин-диони
BG35466A3 (bg) Метод за получаване на производни на клавулановата киселина
BG28845A3 (bg) Метод за получаване на n-алкилдифениламини
BG28066A3 (bg) Метод за получаване на пиридобензодиазепинони
BG33283A3 (bg) Метод за получаване на пиридазинилхидразони
BG32718A3 (bg) Метод за получаване на производни на 4''-деокси-4''- аминоеридромицин-а
BG34459A3 (bg) Метод за получаване на производни на 7 бета- аминотиазолилацетамидо- 3- цефем- 4- карбоновата киселина
BG31378A3 (bg) Метод за получаване на арилалкиламини
BG28057A4 (bg) Метод за получаване на 3-хидроксилетиленхроманоли